新闻中心

新闻中心

News Center
All Categories
Company News
Industry News

Our company participated in the 16th annual meeting of the Chinese Medical Doctor Association Psychiatrist Branch (CPA2020) and held a satellite meeting

Release Time

2022-06-21 15:50

Sponsored by the Chinese Medical Doctor Association and the Chinese Medical Doctor Association Psychiatrist Branch, the 16th Annual Meeting of the Chinese Medical Doctor Association Psychiatrist Branch (CPA2020) will be held on November 19-21, 2020 in the form of an online and offline (Jinan) meeting. Foncoo Pharmaceutical participated in this conference and held a satellite conference. The theme of the satellite conference was: Initial treatment and maintenance of antipsychotic drugs (Interpretation of the American APA (2020) Guidelines for the Treatment of Schizophrenia), and the conference was organized by the Chinese Medical Doctor Association Psychiatrist Branch The current president, Prof. Wang Gaohua, and the first president of the Chinese Medical Doctor Association Psychiatry Branch, Prof. Yu Xin, presided over the session; Prof. Si Tianmei from Peking University Sixth Hospital and Prof. Ma Xiancang from the First Affiliated Hospital of Xi'an Jiaotong University were the speakers. The scene attracted more than 400 doctors and more than 3,000 online attention.

 

▲Satellite meeting poster

 

    

▲Prof. Wang Gaohua and Prof. Yu Xin presided over

 

    

▲Professor Si Tianmei and Professor Ma Xiancang gave lectures

 

▲Thanks to Fangu Pharmaceutical for celebrating the launch of new products (Baiyoulin, Bailangxin)

 

At the end of the meeting, Professor Yu Xin concluded that the initial treatment and maintenance treatment of schizophrenia are very important, but they also face many challenges, which need to be solved by all psychiatrists. The experts and physicians who attended the meeting also warmly congratulated our company on the launch of our new products Baiyoulin (amisulpride tablets) and Bailangxin (quetiapine fumarate sustained-release tablets).

Previous page

Foncoo Pharmaceutical's 2020 Annual Summary Conference was successfully held

To help the epidemic area, Foncoo Pharmaceutical is in action

Next page

Previous page

Foncoo Pharmaceutical's 2020 Annual Summary Conference was successfully held

Next page

To help the epidemic area, Foncoo Pharmaceutical is in action

Related News

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Foncoo Pharmaceutical participated in the 19th National Psychiatry Academic Conference of the Chinese Medical Association

Sponsored by the Chinese Medical Association and the Psychiatry Branch of the Chinese Medical Association, and organized by the Chongqing Medical Association, the Psychiatry Branch of the Chongqing Medical Association, the First Affiliated Hospital of Chongqing Medical University, and the University City Hospital Affiliated to Chongqing Medical University The conference and the Academic Conference on Child and Adolescent Psychiatry were successfully held at Chongqing Yuelai International Conference Center from December 21 to 24, 2021.

2022-05-25

图片名称
2021-Foncoo Public Welfare

2021-Foncoo Public Welfare

On October 15, 2021, Foncoo Pharmaceutical donated 100,000 yuan in cash to the "Gu Xueqiu Pharmacy Education Fund" public welfare student aid project of the Beijing Renren Public Welfare Foundation-Shenyang Pharmaceutical University.

2022-05-25

图片名称
Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Foncoo Pharmaceutical's corporate culture 5.0 was officially released

Official announcement! Seriously, don't be distracted!

2022-05-25

图片名称
Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

Foncoo Pharmaceutical participated in the 16th National Academic Conference on Psychiatric Hospital Management

On October 29-31, 2021, the 16th National Academic Conference on Psychiatric Hospital Management, hosted by the Chinese Hospital Association and the Chinese Hospital Association Psychiatric Hospital Branch, was held in Chongqing.

2022-05-25

图片名称

"Bupropion Hydrochloride Sustained-Release Tablets (II)" exclusively sold by Foncoo Pharmaceuticals was approved in China

Recently, "Bupropion Hydrochloride Sustained-Release Tablets (II) (150mg, 300mg)", exclusively sold by Pangu Pharmaceuticals (Mainland China), was approved by the State Drug Administration and deemed to have passed the consistency evaluation. The product, developed by Shanghai Xuantai Pharmaceuticals, was previously approved by the FDA in August 2017 and was marketed in the United States.

2022-05-25

图片名称
Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

Foncoo Pharmaceutical participated in the 9th China Schizophrenia Forum

From October 22 to 24, 2021, the "Ninth China Schizophrenia Forum" was grandly held in Wuhan. The theme of this forum is "Infection, Inflammation and Schizophrenia".

2022-05-25

图片名称